Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

October 10, 2014
Bioniche Life Sciences Inc. to Publish Comprehensive Phase 3 Clinical Trial Results In The Journal of Urology

September 29, 2014
Bioniche Life Sciences Inc. Reports Fiscal 2014 Year-End Results


Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Investor FAQ

Where are your shares traded?

Bioniche shares trade on the Toronto Stock Exchange under the symbol "BNC".

When did Bioniche go public?

Bioniche Inc. became a public company on February 1, 1992. In July, 1999, Bioniche Inc. was amalgamated with Vetrepharm and Renaissance Life Sciences, a holding company, to form Bioniche Life Sciences Inc., operating both animal and human health businesses under one corporate umbrella.

When is the your fiscal year-end?

The Bioniche fiscal year ends June 30th.

Who are your auditors?

The company's auditors are Ernst & Young, LLP of Montréal, Québec.

Who is your legal counsel?

The Company's legal counsel is Norton Rose Fulbright, Toronto, Ontario.

Who is your transfer agent?

CIBC Mellon Trust Company
c/o Canadian Stock Transfer Company Inc.
P.O. Box 700, Station B
Montreal, QC, H3B 3K3
Tel: 1 (800) 387-0825 / (416) 682-3860
Fax: 1 (888) 249-6189

Who are the members of the Bioniche Board of Directors?

Biographies of the Bioniche senior management team and a listing of the company's Board members can be found here.

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy